Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study
about
Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challengesThe BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortNeuroimaging of Parkinson's disease: Expanding views.Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.The role of biomarkers and imaging in Parkinson's disease.Alterations of diffusion tensor MRI parameters in the brains of patients with Parkinson's disease compared with normal brains: possible diagnostic use.Comorbidity burden of patients with Parkinson's disease and Parkinsonism between 2003 and 2012: A multicentre, nationwide, retrospective study in China.Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body DisordersNetwork analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.MDS clinical diagnostic criteria for Parkinson's disease.Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes.Gut microbiota are related to Parkinson's disease and clinical phenotype.Saskatchewan movement disorders program.Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease PatientsArizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Blood biomarker for Parkinson disease: peptoids.Parkinson's disease-related spatial covariance pattern identified with resting-state functional MRI.Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Medical Record Review to Differentiate between Idiopathic Parkinson's Disease and Parkinsonism: A Danish Record Linkage Study with 10 Years of Follow-Up.Clinical and Epidemiological Factors Associated with Mortality in Parkinson's Disease in a Brazilian Cohort.Simplified conversion method for unified Parkinson's disease rating scale motor examinationsPeripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy FindingsCOPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progAccuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary.Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's diseasePredictors of functional dependency in Parkinson's disease.Biomarkers in Parkinson's disease: Advances and strategies.Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease.Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects.Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.GBA mutations in Parkinson disease: earlier death but similar neuropathological features.A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations.Advances in Biomarker Research in Parkinson's Disease.Baseline motor findings and Parkinson disease prognostic subtypes.Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Pathology of Neurodegenerative Diseases.
P2860
Q26772879-105EB7F5-E2BB-4CDD-BA70-DC01EE0865DAQ28076121-4E4B1B6B-C9E0-4C51-9246-04F7610635AFQ28387732-B4F5CA77-4EF4-41EF-B4F5-7851332885DEQ28553194-68449578-FF67-4341-83E0-9C44CED201F2Q31041660-C56B1341-782A-48D6-8AE8-8E90F3A606FAQ31053308-231E688B-2E96-4CB8-96F8-47E761EFD0BEQ33687062-31B97D14-1BB5-43FA-8B88-4A9199495472Q33874572-29F97FA1-F99D-497B-94AF-FBC57F98F8D8Q34287243-DC6D9A88-053C-4F28-B163-507EB38C8528Q34498274-C4B11B5C-A427-41E8-A283-E2E1DFDF9E9BQ34630647-DCC862B8-66EC-4F58-AC59-DFBB37E3A8D1Q35492461-78C58204-FD2D-49F6-BCC2-98FFB5C6B738Q35559550-089E16AA-19AE-4405-B3E6-3A997852B714Q35855302-BF89A601-F523-491E-8817-68A9697E8817Q36121377-8F435E21-D677-4A42-AD19-2C410F35BEBEQ36182485-E214415E-D461-4EF5-810C-1055FFD8AF36Q36254327-3ED168FF-F607-4B70-98B0-A683CB087420Q36374541-EF9E3E6F-80DF-4B83-8503-9FC8B3F8849BQ36378714-0023FF8B-22D2-48C5-A87E-FE789EAB620BQ36447155-6D4C9B4A-436E-4E68-8190-F1307310AE99Q36477074-9410A391-E75B-4FF4-94E5-A76D8310A3DAQ36563640-384393E4-7924-4192-95F8-0C258794152BQ36616565-5D1251B4-F2C2-460E-A038-40B787C87ACBQ37005403-72606AF9-1CF4-43C4-87D8-65F445AFB322Q37008911-9A2D9BD8-53E1-4380-AA1E-356DE3765C7BQ37062735-22E193E5-9470-46B0-BA43-0428A025C1CCQ37371148-44181C53-0C0E-45AE-AA56-8209BB06212AQ37431507-461A36DA-2DA6-4162-8903-B0F034A99118Q37696024-826E4118-A4F2-4408-B9FB-2913C31A0765Q38377819-37093347-851D-4DA2-853F-B3AAE0309B32Q38603309-E2D6ADC1-7C7B-4B21-BBC9-89EE60AC1D5BQ38611816-B323BB5F-7FFE-40D6-88C8-4AC36C096D0AQ38653383-7189B2CB-EB40-4AFA-A17D-84225F0A7194Q38681599-248B0E50-477E-46B2-B10D-EC1F0AA46F0FQ38737648-556D97C8-8069-4977-A0D7-90620B16612CQ38780220-E9E67776-A68B-4580-9744-15B994D9EC21Q38821003-28D6FBD9-74DF-4F1F-994D-C5DCA06E5370Q38949527-D725CC96-C692-4D33-B8D6-8D8C7B380035Q39010887-43C76699-04C4-4FAE-A975-F56C887E5FFDQ39071493-894CC95A-3EB7-4C76-B717-86EFF85FF170
P2860
Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Low clinical diagnostic accura ...... sease: clinicopathologic study
@ast
Low clinical diagnostic accura ...... sease: clinicopathologic study
@en
Low clinical diagnostic accura ...... sease: clinicopathologic study
@nl
type
label
Low clinical diagnostic accura ...... sease: clinicopathologic study
@ast
Low clinical diagnostic accura ...... sease: clinicopathologic study
@en
Low clinical diagnostic accura ...... sease: clinicopathologic study
@nl
prefLabel
Low clinical diagnostic accura ...... sease: clinicopathologic study
@ast
Low clinical diagnostic accura ...... sease: clinicopathologic study
@en
Low clinical diagnostic accura ...... sease: clinicopathologic study
@nl
P2093
P2860
P1433
P1476
Low clinical diagnostic accura ...... sease: clinicopathologic study
@en
P2093
Brittany N Dugger
Christine M Belden
Erika Driver-Dunckley
Holly A Shill
John N Caviness
Joseph G Hentz
Lucia I Sue
Marwan N Sabbagh
Sandra A Jacobson
P2860
P304
P356
10.1212/WNL.0000000000000641
P407
P577
2014-06-27T00:00:00Z